2022-07-112023-03-312023-03-31false14225907Doctor Dhillon Clinics Limited2024-10-0186900iso4217:GBPxbrli:pure142259072022-07-11142259072023-03-31142259072022-07-112023-03-31142259072022-07-10142259072022-07-10142259072022-07-102022-07-1014225907bus:SmallEntities2022-07-112023-03-3114225907bus:AuditExempt-NoAccountantsReport2022-07-112023-03-3114225907bus:FullAccounts2022-07-112023-03-3114225907bus:PrivateLimitedCompanyLtd2022-07-112023-03-3114225907core:WithinOneYear2023-03-3114225907core:AfterOneYear2023-03-3114225907core:WithinOneYear2022-07-1014225907core:AfterOneYear2022-07-1014225907core:ShareCapital2023-03-3114225907core:SharePremium2023-03-3114225907core:RevaluationReserve2023-03-3114225907core:OtherReservesSubtotal2023-03-3114225907core:RetainedEarningsAccumulatedLosses2023-03-3114225907core:ShareCapital2022-07-1014225907core:SharePremium2022-07-1014225907core:RevaluationReserve2022-07-1014225907core:OtherReservesSubtotal2022-07-1014225907core:RetainedEarningsAccumulatedLosses2022-07-1014225907core:LandBuildings2023-03-3114225907core:PlantMachinery2023-03-3114225907core:Vehicles2023-03-3114225907core:FurnitureFittings2023-03-3114225907core:OfficeEquipment2023-03-3114225907core:NetGoodwill2023-03-3114225907core:IntangibleAssetsOtherThanGoodwill2023-03-3114225907core:ListedExchangeTraded2023-03-3114225907core:UnlistedNon-exchangeTraded2023-03-3114225907core:LandBuildings2022-07-1014225907core:PlantMachinery2022-07-1014225907core:Vehicles2022-07-1014225907core:FurnitureFittings2022-07-1014225907core:OfficeEquipment2022-07-1014225907core:NetGoodwill2022-07-1014225907core:IntangibleAssetsOtherThanGoodwill2022-07-1014225907core:ListedExchangeTraded2022-07-1014225907core:UnlistedNon-exchangeTraded2022-07-1014225907core:LandBuildings2022-07-112023-03-3114225907core:PlantMachinery2022-07-112023-03-3114225907core:Vehicles2022-07-112023-03-3114225907core:FurnitureFittings2022-07-112023-03-3114225907core:OfficeEquipment2022-07-112023-03-3114225907core:NetGoodwill2022-07-112023-03-3114225907core:IntangibleAssetsOtherThanGoodwill2022-07-112023-03-3114225907core:ListedExchangeTraded2022-07-112023-03-3114225907core:UnlistedNon-exchangeTraded2022-07-112023-03-3114225907core:MoreThanFiveYears2022-07-112023-03-3114225907core:Non-currentFinancialInstruments2023-03-3114225907core:Non-currentFinancialInstruments2022-07-1014225907dpl:CostSales2022-07-112023-03-3114225907dpl:DistributionCosts2022-07-112023-03-3114225907core:LandBuildings2022-07-112023-03-3114225907core:PlantMachinery2022-07-112023-03-3114225907core:Vehicles2022-07-112023-03-3114225907core:FurnitureFittings2022-07-112023-03-3114225907core:OfficeEquipment2022-07-112023-03-3114225907dpl:AdministrativeExpenses2022-07-112023-03-3114225907core:NetGoodwill2022-07-112023-03-3114225907core:IntangibleAssetsOtherThanGoodwill2022-07-112023-03-3114225907dpl:GroupUndertakings2022-07-112023-03-3114225907dpl:ParticipatingInterests2022-07-112023-03-3114225907dpl:GroupUndertakingscore:ListedExchangeTraded2022-07-112023-03-3114225907core:ListedExchangeTraded2022-07-112023-03-3114225907dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-07-112023-03-3114225907core:UnlistedNon-exchangeTraded2022-07-112023-03-3114225907dpl:CostSales2022-07-102022-07-1014225907dpl:DistributionCosts2022-07-102022-07-1014225907core:LandBuildings2022-07-102022-07-1014225907core:PlantMachinery2022-07-102022-07-1014225907core:Vehicles2022-07-102022-07-1014225907core:FurnitureFittings2022-07-102022-07-1014225907core:OfficeEquipment2022-07-102022-07-1014225907dpl:AdministrativeExpenses2022-07-102022-07-1014225907core:NetGoodwill2022-07-102022-07-1014225907core:IntangibleAssetsOtherThanGoodwill2022-07-102022-07-1014225907dpl:GroupUndertakings2022-07-102022-07-1014225907dpl:ParticipatingInterests2022-07-102022-07-1014225907dpl:GroupUndertakingscore:ListedExchangeTraded2022-07-102022-07-1014225907core:ListedExchangeTraded2022-07-102022-07-1014225907dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-07-102022-07-1014225907core:UnlistedNon-exchangeTraded2022-07-102022-07-1014225907core:NetGoodwill2023-03-3114225907core:IntangibleAssetsOtherThanGoodwill2023-03-3114225907core:LandBuildings2023-03-3114225907core:PlantMachinery2023-03-3114225907core:Vehicles2023-03-3114225907core:FurnitureFittings2023-03-3114225907core:OfficeEquipment2023-03-3114225907core:AfterOneYear2023-03-3114225907core:WithinOneYear2023-03-3114225907core:ListedExchangeTraded2023-03-3114225907core:UnlistedNon-exchangeTraded2023-03-3114225907core:ShareCapital2023-03-3114225907core:SharePremium2023-03-3114225907core:RevaluationReserve2023-03-3114225907core:OtherReservesSubtotal2023-03-3114225907core:RetainedEarningsAccumulatedLosses2023-03-3114225907core:NetGoodwill2022-07-1014225907core:IntangibleAssetsOtherThanGoodwill2022-07-1014225907core:LandBuildings2022-07-1014225907core:PlantMachinery2022-07-1014225907core:Vehicles2022-07-1014225907core:FurnitureFittings2022-07-1014225907core:OfficeEquipment2022-07-1014225907core:AfterOneYear2022-07-1014225907core:WithinOneYear2022-07-1014225907core:ListedExchangeTraded2022-07-1014225907core:UnlistedNon-exchangeTraded2022-07-1014225907core:ShareCapital2022-07-1014225907core:SharePremium2022-07-1014225907core:RevaluationReserve2022-07-1014225907core:OtherReservesSubtotal2022-07-1014225907core:RetainedEarningsAccumulatedLosses2022-07-1014225907core:NetGoodwill2022-07-1014225907core:IntangibleAssetsOtherThanGoodwill2022-07-1014225907core:LandBuildings2022-07-1014225907core:PlantMachinery2022-07-1014225907core:Vehicles2022-07-1014225907core:FurnitureFittings2022-07-1014225907core:OfficeEquipment2022-07-1014225907core:AfterOneYear2022-07-1014225907core:WithinOneYear2022-07-1014225907core:ListedExchangeTraded2022-07-1014225907core:UnlistedNon-exchangeTraded2022-07-1014225907core:ShareCapital2022-07-1014225907core:SharePremium2022-07-1014225907core:RevaluationReserve2022-07-1014225907core:OtherReservesSubtotal2022-07-1014225907core:RetainedEarningsAccumulatedLosses2022-07-1014225907core:AfterOneYear2022-07-112023-03-3114225907core:WithinOneYear2022-07-112023-03-3114225907core:Non-currentFinancialInstrumentscore:CostValuation2022-07-112023-03-3114225907core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-07-112023-03-3114225907core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-07-112023-03-3114225907core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-07-112023-03-3114225907core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-07-112023-03-3114225907core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-07-112023-03-3114225907core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-07-112023-03-3114225907core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-07-112023-03-3114225907core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-07-112023-03-3114225907core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3114225907core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3114225907core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3114225907core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3114225907core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3114225907core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3114225907core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3114225907core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3114225907core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3114225907core:Non-currentFinancialInstrumentscore:CostValuation2022-07-1014225907core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-07-1014225907core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-07-1014225907core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-07-1014225907core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-07-1014225907core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-07-1014225907core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-07-1014225907core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-07-1014225907core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-07-1014225907bus:Director12022-07-112023-03-31

Doctor Dhillon Clinics Limited

Registered Number
14225907
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2023

Doctor Dhillon Clinics Limited
Company Information
for the period from 11 July 2022 to 31 March 2023

Director

Dr Isha Dhillon

Registered Address

Fulford Lodge 1 Heslington Lane
Fulford
York
YO10 4HW

Registered Number

14225907 (England and Wales)
Doctor Dhillon Clinics Limited
Statement of Financial Position
31 March 2023

Notes

2023

£

£

Fixed assets
Investments31,658,771
1,658,771
Current assets
Debtors2,951
Cash at bank and on hand3,781
6,732
Creditors amounts falling due within one year4(215,995)
Net current assets (liabilities)(209,263)
Total assets less current liabilities1,449,508
Creditors amounts falling due after one year5(1,169,931)
Net assets279,577
Capital and reserves
Called up share capital100
Profit and loss account279,477
Shareholders' funds279,577
The financial statements were approved and authorised for issue by the Director on 1 October 2024, and are signed on its behalf by:
Dr Isha Dhillon
Director
Registered Company No. 14225907
Doctor Dhillon Clinics Limited
Notes to the Financial Statements
for the period ended 31 March 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Dividend income
Dividend income is recognised when the right to receive payment is established.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
2.Average number of employees

2023
Average number of employees during the year1
3.Fixed asset investments

Investments in groups1

Total

££
Cost or valuation
Additions1,658,7711,658,771
At 31 March 231,658,7711,658,771
Net book value
At 31 March 231,658,7711,658,771

Notes

1Investments in group undertakings and participating interests
4.Creditors: amounts due within one year

2023

£
Bank borrowings and overdrafts167,352
Amounts owed to related parties14,977
Other creditors30,853
Accrued liabilities and deferred income2,813
Total215,995
5.Creditors: amounts due after one year

2023

£
Bank borrowings and overdrafts1,169,931
Total1,169,931
6.Related party transactions
The directors operate a directors loan account with the company. At 31 March 2023, the company owed the directors £30,853. This balance has been subject to interest which has been charged in line with the current Bank of England interest rate.